zika virus vaccine

At present, the only flaviviral vaccines available for human use are yellow fever (live attenuated), Japanese encephalitis (inactivated, live attenuated, and chimeric), tick-borne encephalitis (inactivated) vaccines, and the newly marketed dengue vaccine (live attenuated, recombinant, tetravalent; marketed since 2015).

Claims were made by an Indian biotechnology company that two Zika virus vaccine candidates (recombinant and inactivated) can be tested soon; however, no details on the vaccine preparations are currently available in the scientific literature.

In any case, a normal vaccine development cycle usually requires years of preclinical and clinical studies and a Zika virus vaccine for human use is unlikely to be available in the near future.

Zika viurs vaccines related reference

1,ScienceAlert. An Indian company says they have two Zika vaccine candidates ready for pre-clinical trials. Available at: http://www.sciencealert.com/an-indian-company-saysthey-have-2-zika-vaccines-ready-for-pre-clinical-trials.

2,Wong SS-Y, et al., Zika virus infectiondthe next wave after dengue?, Journal of the Formosan Medical Association (2016), http://dx.doi.org/10.1016/j.jfma.2016.02.002